SARS
MCID: SVR001
MIFTS: 62

Severe Acute Respiratory Syndrome (SARS)

Categories: Blood diseases, Infectious diseases, Neuronal diseases, Rare diseases, Respiratory diseases

Aliases & Classifications for Severe Acute Respiratory Syndrome

MalaCards integrated aliases for Severe Acute Respiratory Syndrome:

Name: Severe Acute Respiratory Syndrome 12 74 52 58 3 43 15 17 71
Sars 12 52 58 3
Sars-Cov Infection 12
Sars-1 58

Characteristics:

Orphanet epidemiological data:

58
severe acute respiratory syndrome
Prevalence: <1/1000000 (Europe); Age of onset: All ages;

Classifications:

Orphanet: 58  
Rare respiratory diseases
Rare infectious diseases


External Ids:

Disease Ontology 12 DOID:2945
ICD9CM 34 079.82
MeSH 43 D045169
NCIt 49 C85064
SNOMED-CT 67 398447004
ICD10 32 J12.81 U04 U04.9
MESH via Orphanet 44 D045169
ICD10 via Orphanet 33 U04.9
UMLS via Orphanet 72 C1175175
Orphanet 58 ORPHA140896
UMLS 71 C1175175

Summaries for Severe Acute Respiratory Syndrome

CDC : 3 Severe acute respiratory syndrome (SARS) is a viral respiratory illness caused by a coronavirus called SARS-associated coronavirus (SARS-CoV). SARS was first reported in Asia in February 2003. The illness spread to more than two dozen countries in North America, South America, Europe, and Asia before the SARS global outbreak of 2003 was contained. Since 2004, there have not been any known cases of SARS reported anywhere in the world. The content in this website was developed for the 2003 SARS epidemic. But some guidelines are still being used. Any new SARS updates will be posted on this website.

MalaCards based summary : Severe Acute Respiratory Syndrome, also known as sars, is related to sarcoidosis 1 and covid-19, and has symptoms including fever, headache and dry cough. An important gene associated with Severe Acute Respiratory Syndrome is ACE2 (Angiotensin I Converting Enzyme 2), and among its related pathways/superpathways are Innate Immune System and PEDF Induced Signaling. The drugs Ziprasidone and Liraglutide have been mentioned in the context of this disorder. Affiliated tissues include respiratory tract, testes and lung, and related phenotypes are fever and abnormality of the cardiovascular system

Disease Ontology : 12 A Coronavirus infection that results in infection located in respiratory tract, has material basis in SARS coronavirus (SARS-CoV), which is transmitted by droplet spread of respiratory secretions, transmitted by ingestion of contaminated food, or transmitted by fomites. The infection has symptom fever, has symptom headache, has symptom body aches, has symptom dry cough, and has symptom hypoxia.

Wikipedia : 74 Severe acute respiratory syndrome (SARS) is a viral respiratory disease of zoonotic origin caused by... more...

Related Diseases for Severe Acute Respiratory Syndrome

Diseases in the Respiratory Failure family:

Severe Acute Respiratory Syndrome

Diseases related to Severe Acute Respiratory Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 889, show less)
# Related Disease Score Top Affiliating Genes
1 sarcoidosis 1 32.4 TNF HLA-A CXCL10 CCL5 CCL2
2 covid-19 31.6 TMPRSS2 IL6 CTSL ACE2
3 respiratory failure 31.1 TNF IL6 IL10 CXCL8 CXCL10 CCL5
4 middle east respiratory syndrome 31.0 TMPRSS2 SH2D3A IRF3 IFNB1 CXCL10 CTSL
5 neutropenia 30.8 TNF IL6 IL10 IFNA1 CXCL8
6 bronchopneumonia 30.7 TNF IL6 IL10 CXCL8
7 adult respiratory distress syndrome 30.7 TNF IL6 IL10 CXCL8
8 avian influenza 30.7 TNF IL6 IFNA1 DDX58 CXCL8 CXCL10
9 gastroenteritis 30.7 TNF IL6 IL10 IFNA1 CXCL8
10 pulmonary edema 30.7 TNF IL10 CXCL8
11 west nile virus 30.7 IRF3 IFNA1 DDX58 CLEC4M CD209
12 myocarditis 30.7 TNF IL6 IL10 IFNA1 CCL2
13 venezuelan equine encephalitis 30.6 IFNB1 IFNA1 CXCL10 CCL2
14 vaccinia 30.6 TNF IRF3 IL6 IFNB1 IFNA1
15 allergic encephalomyelitis 30.6 CCL5 CCL2
16 kawasaki disease 30.6 TNF IL6 IL10 CCL2
17 common cold 30.6 TNF IL6 IL10 CXCL8 CCL5
18 dengue disease 30.5 TNF IFNB1 IFNA1 CD209 CCL5
19 bacterial pneumonia 30.5 TNF IL6 IL10 CXCL8
20 hepatitis a 30.5 TNF IL10 IFNA1 CXCL8 CXCL10
21 bronchitis 30.5 TNF IL6 IL10 CXCL8 CXCL10 CCL5
22 orchitis 30.5 TNF IL6 IL10
23 diarrhea 30.5 TNF IRF3 IL6 IL10 IFNB1 IFNA1
24 vasculitis 30.5 TNF IL6 IL10 CCL2
25 hypereosinophilic syndrome 30.5 IL10 IFNA1 CXCL8 CCL5
26 lung disease 30.4 TNF IL6 IL10 CXCL8 CXCL10 CCL5
27 bronchiolitis obliterans 30.4 TNF IL6 IL10 CXCL8
28 sleeping sickness 30.4 IL6 IL10 CTSL
29 acquired immunodeficiency syndrome 30.4 TNF IL6 IL10 IFNA1
30 allergic contact dermatitis 30.4 TNF IL6 IL10 CXCL8 CCL2
31 rhinitis 30.4 TNF IL6 IL10 CXCL8 CCL5
32 mycobacterium tuberculosis 1 30.4 TNF IL10 IFNB1 CXCL10 CD209
33 pulmonary tuberculosis 30.4 TNF IL6 IL10 CCL2
34 syphilis 30.4 TNF IL6 CD209
35 chlamydia pneumonia 30.4 TNF IL6 IL10 CXCL8 CCL2
36 chlamydia 30.4 TNF IL6 IL10 CXCL8 CCL2
37 pericarditis 30.4 TNF IL6 CXCL8
38 disseminated intravascular coagulation 30.3 TNF IL6 IL10
39 haemophilus influenzae 30.3 TNF CXCL8
40 lymphocytic choriomeningitis 30.3 IRF3 IL6 DDX58 CXCL8
41 schistosomiasis 30.3 TNF IL10 CCL5 CCL2
42 leukostasis 30.3 TNF IL6 CCL2
43 contact dermatitis 30.3 TNF IL6 IL10 CXCL8 CXCL10 CCL2
44 toxic shock syndrome 30.3 TNF IL6 IL10 CXCL8
45 streptococcal toxic-shock syndrome 30.3 TNF IL6 CXCL8
46 colitis 30.2 TNF IL6 IL10 CXCL8
47 chagas disease 30.2 TNF IL6 IL10 CXCL8 CCL5 CCL2
48 mycoplasma pneumoniae pneumonia 30.2 TNF IL6 IL10
49 endophthalmitis 30.2 TNF IL6 CXCL8
50 endocarditis 30.2 TNF IL6 IL10 CXCL8
51 conjunctivitis 30.2 TNF IL6 IL10 CXCL8 CCL2
52 erythema multiforme 30.2 TNF IL6 CXCL8
53 human immunodeficiency virus type 1 30.2 TNF IRF3 IL10 HLA-A CXCL10 CLEC4M
54 sting-associated vasculopathy with onset in infancy 30.2 IRF3 IFNB1 DDX58
55 visceral leishmaniasis 30.2 TNF IL10 CXCL8
56 trypanosomiasis 30.2 TNF IL6 IL10 CXCL8 CXCL10 CCL5
57 gout 30.2 TNF IL6 CXCL8 CCL2
58 leishmaniasis 30.2 TNF IL6 IL10 IFNB1 CXCL8 CCL2
59 thyroiditis 30.1 TNF IL6 IL10 IFNA1
60 purpura 30.1 TNF IL6 IL10
61 chickenpox 30.1 TNF IL6 IL10 IFNB1 IFNA1
62 dermatitis 30.1 TNF IL6 IL10 CXCL8
63 lassa fever 30.1 IRF3 IFNA1 DDX58 CD209
64 bronchiolitis 30.1 TNF IL6 IL10 IFNA1 CXCL8 CXCL10
65 yellow fever 30.1 IL6 IFNB1 CXCL10 CCL5 CCL2
66 thrombocytopenia 30.1 TNF IL6 IL10 IFNB1 IFNA1 HLA-A
67 streptococcus pneumonia 30.1 TNF IL6 IL10 CXCL8
68 plague 30.1 TNF IL6 IL10 DDX58
69 perinatal necrotizing enterocolitis 30.1 TNF IL6 IL10 CXCL8
70 pneumonia 30.1 TNF IL6 IL10 IFNB1 IFNA1 CXCL8
71 crohn's disease 30.1 TNF IL6 IL10 CXCL8 CCL2
72 duodenal ulcer 30.1 TNF IL6 IL10 CXCL8
73 chronic kidney disease 30.1 TNF IL6 IL10 HLA-A CCL2 ACE2
74 exanthem 30.1 TNF SH2D3A IL6 IL10 IFNA1 CXCL8
75 acute pancreatitis 30.1 TNF IL6 IL10 CXCL8
76 stomatitis 30.0 TNF MX1 IL6 IL10 IFNB1 IFNA1
77 hand, foot and mouth disease 30.0 IL6 IL10 DDX58
78 vascular disease 30.0 TNF IL6 IL10 CCL2 ACE2
79 vaginal discharge 30.0 TNF IL6 CXCL8
80 echinococcosis 30.0 TNF IL6 IL10
81 keratoconjunctivitis 30.0 TNF IL6 CXCL8 CCL5 CCL2
82 hepatitis 30.0 TNF IRF3 IFNA1 DDX58 CXCL10 CLEC4M
83 periodontitis 30.0 TNF IL6 IL10 CXCL8 CCL2
84 macular retinal edema 30.0 TNF IL6 IFNB1 CXCL8 CCL2
85 spinal cord injury 30.0 TNF IL6 CXCL8
86 appendicitis 30.0 TNF IL6 IL10 CXCL8 CCL2
87 pharyngitis 30.0 TNF IL6 CXCL8
88 localized scleroderma 30.0 TNF IL6 CXCL10 CCL5
89 peptic ulcer disease 30.0 TNF IL10 CXCL8
90 obsessive-compulsive disorder 30.0 TNF IL6 CXCL8 CCL2
91 fibromyalgia 30.0 TNF IL6 IL10 CXCL8 CCL2
92 respiratory allergy 30.0 TNF IL6 IL10 CXCL8 CCL5
93 septic arthritis 30.0 TNF IL6 CXCL8
94 ulcerative colitis 30.0 TNF IL6 IL10 CXCL8
95 rabies 29.9 MX1 IRF3 IFNA1 DDX58 CXCL10 CCL5
96 cowpox 29.9 MX1 IL6 CXCL8
97 endometriosis 29.9 IL6 CXCL8 CCL5 CCL2
98 chronic fatigue syndrome 29.9 TNF IL6 IL10 CXCL8 CCL5
99 gastritis 29.9 TNF IL6 IL10 CXCL8 CCL5
100 viral hepatitis 29.9 TNF MX1 IL6 IL10 IFNA1
101 tetanus 29.9 TNF IL6 IL10 HLA-A
102 pulmonary disease, chronic obstructive 29.9 TNF IL6 IL10 CXCL8 CXCL10 CCL5
103 chikungunya 29.9 TNF IL6 DDX58 CD209 CCL5 CCL2
104 hepatitis b 29.9 TNF MX1 IL6 IFNB1 IFNA1 CXCL8
105 prostatitis 29.9 TNF IL6 IL10 CXCL8
106 tonsillitis 29.9 TNF IL6 IL10 CXCL8
107 hemophagocytic lymphohistiocytosis 29.9 TNF IL10 CXCL8
108 cholangitis 29.9 TNF IL6 IL10 CXCL8
109 corneal disease 29.9 TNF IL6 IL10 CXCL8
110 meningitis 29.8 TNF IL6 IL10 CXCL8 CCL5 CCL2
111 toxic encephalopathy 29.8 TNF IL6 CCL2
112 rubella 29.8 TNF IL6 IL10 IFNB1 HLA-A DDX58
113 meningoencephalitis 29.8 TNF IL6 IL10 CXCL10 CCL5
114 swine influenza 29.8 TNF MX1 IFNB1 IFNA1 DDX58
115 cytomegalovirus infection 29.8 TNF IRF3 IL6 HLA-A CXCL8 CCL5
116 peritonitis 29.8 TNF IL6 IL10 CXCL8 CCL5 CCL2
117 cystitis 29.8 TNF IL6 CXCL8 CXCL10 CCL2
118 atherosclerosis susceptibility 29.8 TNF IL6 CXCL8 CCL2
119 mastitis 29.8 IL6 CXCL8 CCL5
120 viral pneumonia 29.8 TNF IL6 IL10 IFNB1 DDX58 CXCL8
121 peripheral nervous system disease 29.8 TNF IL6 IL10 IFNB1 CXCL8 CCL2
122 herpes simplex 29.8 TNF IRF3 IL6 IFNB1 IFNA1 DDX58
123 newcastle disease 29.7 TNF IRF3 IFNB1 IFNA1 DDX58 CXCL10
124 suppression of tumorigenicity 12 29.7 TNF TMPRSS2 IL6 CXCL8
125 aspergillosis 29.7 TNF IL6 IL10 CXCL8 CXCL10 CD209
126 human immunodeficiency virus infectious disease 29.7 TNF MX1 IL10 IFNA1 HLA-A CLEC4M
127 dermatitis, atopic 29.7 TNF IL6 IL10 CXCL8 CXCL10 CCL5
128 eye disease 29.7 TNF IL6 IL10 CXCL8 CXCL10 CCL5
129 leukemia, acute myeloid 29.7 TNF IL6 IL10 IFNA1 HLA-A CXCL8
130 myositis 29.7 TNF IL6 IFNA1 CXCL8 CXCL10 CCL2
131 coronavirus infectious disease 29.6 TNF TMPRSS2 SH2D3A IRF3 IL6 IFNB1
132 hypertension, essential 29.6 TNF IL6 IL10 CXCL8 CCL5 CCL2
133 pertussis 29.6 TNF IL6 IL10 CXCL8 CCL5 CCL2
134 immune deficiency disease 29.6 TNF IL6 IL10 IFNB1 IFNA1 HLA-A
135 myocardial infarction 29.6 TNF IL6 IL10 CXCL8 CCL5 CCL2
136 hepatitis c 29.6 TNF MX1 IRF3 IL10 IFNB1 IFNA1
137 osteoporosis 29.6 TNF IL6 IL10 IFNA1 CXCL8 CCL2
138 autoimmune disease 29.6 TNF IL6 IL10 IFNB1 IFNA1 HLA-A
139 bacterial infectious disease 29.6 TNF MX1 IRF3 IL6 IL10 IFNB1
140 demyelinating disease 29.6 TNF IL6 IL10 IFNB1 IFNA1 CXCL10
141 proteasome-associated autoinflammatory syndrome 1 29.5 TNF IL6 IL10 IFNA1 CXCL8 CXCL10
142 nasopharyngeal carcinoma 29.5 TNF IL6 IL10 HLA-A CXCL8
143 measles 29.5 TNF IRF3 IL6 IFNB1 IFNA1 HLA-A
144 mouth disease 29.5 MX1 IRF3 IL6 IL10 IFNA1 DDX58
145 asthma 29.4 TNF IL6 IL10 IFNB1 CXCL8 CXCL10
146 psoriasis 29.4 TNF IL6 IL10 HLA-A DDX58 CXCL8
147 myeloma, multiple 29.4 TNF IL6 IL10 IFNA1 CXCL8 CTRL
148 influenza 29.3 TNF TMPRSS2 MX1 IRF3 IL6 IFNB1
149 inflammatory bowel disease 29.3 TNF IL6 IL10 IFNB1 CXCL8 CXCL10
150 arthritis 29.3 TNF IL6 IL10 CXCL8 CTSL CCL5
151 diabetes mellitus 29.2 TNF IL6 IL10 HLA-A CXCL8 CXCL10
152 multiple sclerosis 29.2 TNF MX1 IL6 IL10 IFNB1 IFNA1
153 encephalitis 29.0 TNF MX1 IRF3 IL6 IL10 IFNB1
154 viral encephalitis 28.9 TNF MX1 IL6 IL10 IFNB1 IFNA1
155 malaria 28.9 TNF IL6 IL10 IFNB1 IFNA1 HLA-A
156 viral infectious disease 28.7 TNF MX1 IRF3 IL6 IL10 IFNB1
157 systemic lupus erythematosus 28.3 TNF MX1 IRF3 IL6 IL10 IFNB1
158 sarcosinemia 11.5
159 lymphopenia 10.7
160 oral erosive lichen 10.7 IFNB1 IFNA1
161 punctate inner choroidopathy 10.6 TNF IL10
162 tropical endomyocardial fibrosis 10.6 TNF IL10
163 eastern equine encephalitis 10.6 SH2D3A IFNA1 CD209
164 croup 10.6 SH2D3A DDX58 ACE2
165 autoimmune myocarditis 10.6 TNF CCL2
166 west nile virus infection 10.6 IRF3 CCL5
167 neurosyphilis 10.6 IL10 CXCL8 CXCL10
168 multifocal choroiditis 10.6 TNF IL10
169 palladium allergic contact dermatitis 10.6 TNF IL10 CCL2
170 primary peritoneal carcinoma 10.6 IL10 CXCL8 CXCL10
171 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.6
172 herpes simplex virus keratitis 10.6 IFNB1 CXCL8 CCL2
173 spotted fever rickettsiosis 10.6 TNF IL10 CCL5
174 respiratory syncytial virus infectious disease 10.5 IFNB1 CCL5
175 cytomegalovirus retinitis 10.5 TNF IL10 HLA-A
176 mycetoma 10.5 IL10 CXCL8 CCL5
177 engraftment syndrome 10.5 IFNA1 CXCL8
178 periapical granuloma 10.5 CXCL8 CCL5 CCL2
179 orofacial granulomatosis 10.5 TNF IL10 CCL5
180 external pathological resorption 10.5 TNF IL6
181 vulvovaginitis 10.5 IL10 CXCL8 CCL5
182 macs syndrome 10.5 TNF IL10 IFNA1
183 nephrosclerosis 10.5 TNF CCL2 ACE2
184 chronic inflammatory demyelinating polyradiculoneuropathy 10.5 IL10 IFNB1 CCL5
185 retinal vasculitis 10.5 TNF IFNB1 CCL2
186 tuberculous meningitis 10.5 TNF CXCL8 CCL2
187 chilblain lupus 1 10.5 IRF3 IFNA1 DDX58
188 status asthmaticus 10.5 IL10 CXCL8 CCL5
189 invasive aspergillosis 10.5 IL10 CXCL8 CXCL10
190 extrapulmonary tuberculosis 10.5 TNF IL10 CCL2
191 obesity-hypoventilation syndrome 10.5 IL6 CCL5
192 secondary progressive multiple sclerosis 10.5 IL10 IFNB1 CXCL10 CCL2
193 trichuriasis 10.5 TNF IL10 CXCL8
194 posterior urethral valves 10.5 TNF IL6 ACE2
195 chronic eosinophilic pneumonia 10.5 IL6 CCL5 CCL2
196 herpes zoster 10.5 TNF IL10 IFNA1 HLA-A
197 pleurisy 10.5 TNF CXCL8 CCL2
198 spotted fever 10.5 TNF IL10 CXCL10 CCL5
199 proliferative glomerulonephritis 10.5 IL6 CXCL10 CCL2
200 scorpion envenomation 10.5 TNF IL6 CCL5
201 pulmonary sarcoidosis 10.5 TNF CCL5 CCL2
202 pleural tuberculosis 10.5 TNF CXCL8 CXCL10 CCL2
203 denture stomatitis 10.5 IL6 CXCL8 CCL2
204 acute transverse myelitis 10.5 IL6 IL10 CXCL8
205 human herpesvirus 8 10.5 IL6 IFNA1 HLA-A CD209
206 autoimmune uveitis 10.5 TNF IL10 IFNA1 CCL2
207 acute generalized exanthematous pustulosis 10.5 MX1 CXCL8
208 papillary conjunctivitis 10.5 IL6 CXCL8 CCL2
209 angioimmunoblastic lymphadenopathy with dysproteinemia 10.5 TNF IL6
210 tenosynovitis 10.5 TNF SH2D3A IL6
211 retinal artery occlusion 10.5 IL6 IL10 CCL2
212 churg-strauss syndrome 10.5 TNF IL10 CXCL8
213 null-cell leukemia 10.5 TNF IL6 IFNA1
214 dermatitis herpetiformis 10.4 TNF IL10 CXCL8
215 aseptic meningitis 10.4 TNF IL10 CXCL8
216 anaerobic pneumonia 10.4 TNF IL6 CCL5
217 peyronie's disease 10.4 IL6 IFNA1 HLA-A CCL2
218 taeniasis 10.4 TNF IL10 CTSL
219 toxicodendron dermatitis 10.4 TNF CXCL8
220 retinal vascular occlusion 10.4 IL6 CXCL8 CCL2
221 post-transplant lymphoproliferative disease 10.4 TNF IL6 IL10
222 allergic conjunctivitis 10.4 TNF IL10 CXCL8
223 eales disease 10.4 TNF IL6 IL10
224 chemical colitis 10.4 TNF IL6 IL10
225 hypopyon 10.4 TNF IL6 IL10
226 hepatitis e 10.4 TNF IFNB1 DDX58
227 neuromyelitis optica 10.4 IL6 IFNA1 CXCL10
228 idiopathic anterior uveitis 10.4 TNF IL6 CXCL8
229 bacteriuria 10.4 IL6 CXCL8 CCL2
230 iridocyclitis 10.4 TNF IL6 IL10
231 chorioretinitis 10.4 TNF IL6 IL10
232 eosinophilic pneumonia 10.4 IL6 CXCL8 CCL5
233 fungal meningitis 10.4 TNF IL6 IL10
234 ascaris lumbricoides infection 10.4 IL6 IL10 CXCL8
235 silicosis 10.4 TNF IL10 CXCL8 CCL2
236 autoimmune disease of eyes, ear, nose and throat 10.4 TNF IL6 IL10
237 lymphadenitis 10.4 TNF IL10 CXCL8 CD209
238 listeria meningitis 10.4 TNF IFNB1
239 primary systemic mycosis 10.4 TNF IL6 IL10
240 ureteral disease 10.4 TNF IL6 CCL2
241 intermediate uveitis 10.4 TNF IL6 IL10
242 carotid stenosis 10.4 TNF IL10 CXCL8
243 nail disease 10.4 TNF IL6 IFNA1
244 autoimmune gastritis 10.4 TNF IL6 IL10
245 trachoma 10.4 TNF IL6 IL10
246 autoimmune disease of blood 10.4 TNF IL6 IL10
247 peptic esophagitis 10.4 TNF IL6 CXCL8
248 periapical periodontitis 10.4 TNF IL6 CXCL8
249 dental pulp disease 10.4 TNF IL6 CXCL8
250 panuveitis 10.4 TNF IL6 IL10
251 cardiomyopathy, familial hypertrophic, 20 10.4 TNF IL6 CXCL8
252 trichomoniasis 10.4 TNF IL6 CXCL8
253 juvenile arthritis 10.4 IL6 IL10 HLA-A CXCL8
254 urethritis 10.4 TNF IL6 CXCL8
255 splenic disease 10.4 TNF IL6 IL10
256 cervicitis 10.4 TNF IL6 CXCL8
257 tropical spastic paraparesis 10.4 IL6 IL10 CCL5
258 fuchs' heterochromic uveitis 10.4 IL6 CXCL8
259 autoimmune disease of skin and connective tissue 10.4 TNF IL6 IL10
260 blood group, globoside system 10.4 TNF IL6 CXCL8
261 burning mouth syndrome 10.4 TNF IL6 CXCL8
262 cecal disease 10.4 TNF IL6 CXCL8
263 stachybotrys chartarum 10.4 TNF IL6 CCL5 CCL2
264 pyelitis 10.4 TNF IL6 CXCL8
265 rheumatic fever 10.4 TNF IL6 IL10
266 fallopian tube disease 10.4 TNF IL6 CXCL8
267 neonatal jaundice 10.4 TNF IL6 IL10
268 pulpitis 10.4 TNF IL6 CXCL8
269 relapsing polychondritis 10.4 IL6 IL10 CXCL8 CCL2
270 acute pyelonephritis 10.4 IL6 IL10 CXCL8 CXCL10
271 rheumatic heart disease 10.4 TNF IL6 IL10
272 mixed connective tissue disease 10.4 TNF IL6 IL10
273 endometritis 10.4 TNF IL6 CXCL8
274 graft-versus-host disease 10.4 TNF IL6 IL10 HLA-A
275 rosacea 10.4 TNF IL6 CXCL8
276 adult-onset still's disease 10.4 TNF IL6 CXCL8
277 plasmodium vivax malaria 10.4 TNF IL6 IL10 CXCL10
278 osteonecrosis 10.4
279 endocardium disease 10.4 TNF IL6 CXCL8
280 sebaceous gland disease 10.4 TNF IL6 CXCL8
281 lymph node disease 10.4 TNF IL6 IL10
282 b cell deficiency 10.4 TNF IL6 IL10
283 periodic fever, familial, autosomal dominant 10.4 TNF IL6 CXCL8
284 apnea, obstructive sleep 10.4 TNF IL6 CXCL8
285 nontuberculous mycobacterial lung disease 10.4 TNF HLA-A
286 shigellosis 10.4 TNF IL10 CXCL8
287 central nervous system lymphoma 10.4 TNF IL6 IL10
288 ectodermal dysplasia 1, hypohidrotic, x-linked 10.4 TNF IL6 IL10 CCL2
289 primary progressive multiple sclerosis 10.4 TNF MX1 IL10 IFNB1
290 autoimmune disease of gastrointestinal tract 10.4 TNF IL6 IL10
291 meconium aspiration syndrome 10.4 TNF IL6 CXCL8 ACE2
292 salivary gland disease 10.4 TNF IL6 IL10
293 temporal arteritis 10.4 TNF IL6 CCL5 CCL2
294 idiopathic neutropenia 10.4 TNF IL6 IL10 CCL5
295 melioidosis 10.3 TNF IL6 IL10
296 african tick-bite fever 10.3 TNF IL6 IL10 CCL5
297 pulmonary fibrosis 10.3
298 testicular disease 10.3 TNF IL6 IL10 CD209
299 ileus 10.3 TNF IL6 IL10 CCL2
300 irritant dermatitis 10.3 TNF IL6 CXCL8 CXCL10
301 hypotrichosis 1 10.3 TNF IL6 IL10
302 autoimmune disease of exocrine system 10.3 TNF IL6 IL10 IFNA1
303 ectodermal dysplasia 10b, hypohidrotic/hair/tooth type, autosomal recessive 10.3 TNF IL6 IL10 CCL2
304 cholangitis, primary sclerosing 10.3 TNF IL6 IL10 HLA-A
305 limb ischemia 10.3 TNF IL6 CCL2
306 autoimmune disease of endocrine system 10.3 TNF IL6 IL10 IFNA1
307 clonorchiasis 10.3 TNF IL10 CXCL8 CTSL
308 vitreous disease 10.3 TNF IL6 CXCL8 CCL2
309 gastric ulcer 10.3 TNF IL6 CXCL8
310 penile disease 10.3 TNF IL6 IFNB1 IFNA1
311 castleman disease 10.3 IL6 IL10 IFNA1 CXCL8
312 ileitis 10.3 TNF IL6 IL10 CCL5
313 spondylitis 10.3 TNF IL6 IL10
314 cellulitis 10.3 TNF IL6 IL10
315 filariasis 10.3 TNF IL6 IL10 CCL5
316 autoimmune disease of peripheral nervous system 10.3 TNF IL6 IL10 IFNB1
317 leukemia, acute monocytic 10.3 TNF IL6 CXCL8 CCL2
318 blood coagulation disease 10.3 TNF IL6 IL10 IFNA1
319 vein disease 10.3 TNF IL6 CXCL8 CCL2
320 transverse myelitis 10.3 TNF IL6 IL10 CXCL8
321 obstructive jaundice 10.3 TNF IL6 CXCL8 CCL2
322 progressive myoclonus epilepsy 8 10.3 TNF IL6 IL10 CXCL8
323 allergic hypersensitivity disease 10.3 TNF IL10 CXCL8 CXCL10 CCL5
324 salmonellosis 10.3 TNF IL6 IL10
325 spinal cord disease 10.3 TNF IL6 IL10 IFNB1
326 congenital cytomegalovirus 10.3 TNF CCL2
327 peripheral artery disease 10.3 TNF IL6 CCL2
328 funisitis 10.3 TNF IL6 IL10 CXCL8
329 chronic conjunctivitis 10.3 TNF IL6 IL10 CXCL8
330 lyme disease 10.3 TNF IL6 IFNB1 IFNA1
331 endometrial disease 10.3 TNF IL6 IL10 CXCL8
332 lichen disease 10.3 TNF IL6 IL10 CXCL8
333 varicose veins 10.3 TNF IL6 CXCL8 CCL2
334 retinal vascular disease 10.3 TNF IL6 CXCL8 CCL2
335 gingival disease 10.3 TNF IL6 IL10 CXCL8
336 lacrimal apparatus disease 10.3 TNF IL6 IL10 CXCL8
337 chronic mucocutaneous candidiasis 10.3 TNF IL6 IL10 IFNA1
338 fasciitis 10.3 TNF IL6 IFNA1 CXCL8
339 middle ear disease 10.3 TNF IL6 IL10 CXCL8
340 coccidiosis 10.3 TNF IL6 IL10 CXCL8
341 dysentery 10.3 TNF IL6 IL10 CXCL8
342 viral meningitis 10.3 IL6 CXCL8 CXCL10 CCL5 CCL2
343 bacterial sepsis 10.3 TNF IL6 IL10 CXCL8
344 paranasal sinus disease 10.3 TNF IL6 IL10 CXCL8
345 preterm premature rupture of the membranes 10.3 TNF IL6 IL10 CXCL8
346 childhood type dermatomyositis 10.3 TNF MX1 IL6 IFNA1
347 overnutrition 10.3 TNF IL6 IL10 CCL2
348 opportunistic mycosis 10.3 TNF IL6 IL10 CXCL8
349 fungal infectious disease 10.3 TNF IL6 IL10 CXCL8
350 bacterial vaginosis 10.3 TNF IL6 IL10 CXCL8
351 commensal bacterial infectious disease 10.3 TNF IL6 IL10 CXCL8
352 monocytic leukemia 10.3 TNF IL6 CXCL8 CCL2
353 brucellosis 10.3 TNF IL6 IL10 CXCL8
354 paracoccidioidomycosis 10.3 TNF IL6 IL10 CXCL10 CD209
355 stomach disease 10.3 TNF IL6 IL10 CXCL8
356 tick-borne encephalitis 10.3 IL10 IFNB1 IFNA1 DDX58 CXCL10 CD209
357 arteriosclerosis 10.3 IL6 IL10 CCL5 CCL2
358 alopecia areata 10.3 TNF IL6 IL10 HLA-A CXCL10
359 alcoholic liver cirrhosis 10.3 TNF IL6 IL10 CXCL8
360 spondyloarthropathy 10.3 TNF IL6 IL10 HLA-A CCL2
361 intracranial aneurysm 10.3 TNF CCL2 ACE2
362 atrophic gastritis 10.3 TNF IL6 IL10 CXCL8
363 gastroesophageal reflux 10.3 TNF IL6 CXCL8 CCL2
364 aortic aneurysm, familial abdominal, 1 10.3 IL6 CTSL CCL2
365 sclerosing cholangitis 10.3 TNF IL6 IL10 CXCL8
366 hyper ige syndrome 10.3 TNF IL6 IL10 CXCL8
367 irritable bowel syndrome 10.3 TNF IL6 IL10 CXCL8
368 glucose metabolism disease 10.3 TNF IL6 IL10 CCL2
369 cytokine deficiency 10.3
370 cranial nerve disease 10.3 TNF IL6 IFNB1
371 legionellosis 10.3 TNF IL6 CXCL8
372 pleural disease 10.3 TNF IL6 CXCL8
373 cryoglobulinemia 10.3 TNF IL6 IL10 IFNA1 CXCL10
374 microphthalmia with limb anomalies 10.3 MX1 IRF3 IFNB1 IFNA1 DDX58
375 acquired metabolic disease 10.3 TNF IL6 IL10 CCL2
376 candidiasis 10.3 TNF IL6 IL10 CXCL8
377 takayasu arteritis 10.3 TNF IL6 IL10 HLA-A CCL5
378 autoimmune hepatitis 10.3 TNF IL6 IL10 IFNA1 HLA-A
379 extrinsic allergic alveolitis 10.3 IL6 IL10 CXCL8 CCL5 CCL2
380 q fever 10.3 TNF IL6 IL10 CCL5 CCL2
381 potocki-shaffer syndrome 10.3 TNF IL6 IL10 IFNA1 CXCL10
382 retinal vein occlusion 10.3 TNF IL6 CXCL8 CXCL10 CCL2
383 upper respiratory tract disease 10.3 TNF IL6 IL10 CXCL8
384 food allergy 10.3 TNF IL10 CXCL8
385 hair disease 10.3 TNF IL6 IL10
386 parasitic helminthiasis infectious disease 10.3 TNF IL6 IL10 CTSL
387 non-alcoholic steatohepatitis 10.2 TNF IL6 CXCL8 CXCL10 CCL2
388 aphthous stomatitis 10.2 TNF IL6 IL10 HLA-A CXCL8
389 extrinsic cardiomyopathy 10.2 TNF IL6 IL10 IFNB1 CCL2
390 familial mediterranean fever 10.2 TNF IL6 IL10 HLA-A CXCL8
391 drug-induced lupus erythematosus 10.2 TNF IL6 IL10 CXCL8 CCL2
392 essential thrombocythemia 10.2 TNF IL6 IFNA1 CXCL8
393 optic neuritis 10.2 TNF IL6 IL10 CXCL8 CXCL10
394 leptospirosis 10.2 TNF IL6 IL10 CXCL8 CCL2
395 complex regional pain syndrome 10.2 TNF IL6 IL10 CXCL8 CCL2
396 aggressive periodontitis 10.2 TNF IL6 IL10 CXCL8 CCL2
397 cerebral palsy 10.2 TNF IL6 IL10 CXCL8
398 acute cystitis 10.2 TNF IL6 IL10 CXCL8 CCL2
399 pulmonary alveolar proteinosis 10.2 TNF IL6 IL10 CXCL8 CCL2
400 pneumoconiosis 10.2 TNF IL6 IL10 CXCL8 CCL2
401 chorioamnionitis 10.2 TNF IL6 IL10 CXCL8 CCL2
402 bacterial meningitis 10.2 TNF IL6 IL10 CXCL8 CCL2
403 cutaneous leishmaniasis 10.2 TNF IL6 IL10 CXCL8 CCL2
404 uveal disease 10.2 TNF IL6 IL10 CXCL8 CCL2
405 alcoholic hepatitis 10.2 TNF IL6 IL10 CXCL8 CCL2
406 sleep apnea 10.2 TNF IL6 IL10 CXCL8 CCL2
407 juvenile rheumatoid arthritis 10.2 TNF IL6 IL10 CXCL8 CCL2
408 anus disease 10.2 TNF IL6 IL10 IFNA1 CXCL8
409 skin sarcoidosis 10.2 TNF IFNA1
410 rectal disease 10.2 TNF IL6 IL10 IFNA1 CXCL8
411 bone inflammation disease 10.2 TNF IL6 IL10 CXCL8 CCL2
412 vaginitis 10.2 TNF IL6 IL10 CXCL8 CCL5
413 hypersensitivity reaction type iv disease 10.2 TNF IL6 IL10 IFNA1 CXCL8
414 nasal cavity disease 10.2 TNF IL6 IL10 CXCL8 CCL5
415 nose disease 10.2 TNF IL6 IL10 CXCL8 CCL5
416 gingival overgrowth 10.2 TNF IL6 CXCL8 CTSL
417 hantavirus hemorrhagic fever with renal syndrome 10.2 TNF MX1 IL6 DDX58 CXCL10
418 myxoid liposarcoma 10.2 IL6 CXCL8 CCL2
419 esophagitis 10.2 TNF IL6 IL10 CXCL8 CCL5
420 myelitis 10.2 TNF IL6 IL10 IFNB1 CXCL8
421 listeriosis 10.2 TNF IRF3 IL6 IL10 IFNB1
422 leukocyte disease 10.2 TNF IL6 IL10 IFNA1 CXCL8
423 cutaneous lupus erythematosus 10.2 TNF MX1 IL6 IL10 IFNA1
424 eye lymphoma 10.2 IL6 IL10
425 sudden infant death syndrome 10.2 TNF IL6 IL10 CXCL8
426 immune system disease 10.2 TNF IL6 IL10 IFNB1
427 combined t cell and b cell immunodeficiency 10.2 TNF IL6 IL10 IFNA1 CXCL8
428 reactive arthritis 10.2 TNF IL6 IL10 IFNB1 CXCL8
429 aicardi-goutieres syndrome 10.2 MX1 IRF3 IFNB1 IFNA1 DDX58 CXCL10
430 intestinal disease 10.2 TNF IL6 IL10 CXCL8
431 kaposi sarcoma 10.2 IRF3 IL6 IFNB1 IFNA1 CXCL8
432 lipoprotein quantitative trait locus 10.2 TNF IL6 IL10 CXCL8
433 placenta disease 10.2 TNF IL6 CXCL8
434 radiculopathy 10.2 IL6 IL10 IFNA1 CXCL8 CCL5 CCL2
435 storm syndrome 10.2
436 primary biliary cirrhosis 10.2 TNF IL6 IL10 IFNA1 HLA-A CCL2
437 leprosy 3 10.2 TNF IL6 IL10 CXCL8 CXCL10 CD209
438 kidney disease 10.1
439 parasitic protozoa infectious disease 10.1 TNF IL6 IL10 CXCL8 CXCL10 CCL2
440 plasmodium falciparum malaria 10.1 TNF IL6 IL10
441 pulmonary hypertension 10.1 TNF IL6 IL10 CXCL8 CCL2
442 retinal detachment 10.1 TNF IL6 IL10 CXCL8 CXCL10 CCL2
443 sickle cell anemia 10.1 TNF IL6 CXCL8
444 autoimmune disease of musculoskeletal system 10.1 TNF IL6 IL10 IFNA1 CXCL8 CCL2
445 celiac disease 1 10.1 TNF IL6 IL10 IFNA1 HLA-A CXCL8
446 gingivitis 10.1 TNF IL6 IL10 CXCL8 CCL5 CCL2
447 dengue virus 10.1
448 myeloid leukemia 10.1
449 dengue shock syndrome 10.1 TNF IL6 IFNA1 HLA-A CLEC4M CD209
450 otitis media 10.1 TNF IL6 IL10 CXCL8 CCL5 CCL2
451 common variable immunodeficiency 10.1 TNF IL6 IL10 HLA-A
452 subacute sclerosing panencephalitis 10.1 TNF MX1 IL6 IL10 IFNA1 CXCL10
453 helix syndrome 10.1
454 cardiac arrest 10.1
455 myopathy 10.1
456 bronchiectasis 10.1
457 vaginal disease 10.1 TNF IL6 IL10 IFNA1 CXCL8 CCL5
458 conjunctival disease 10.1 TNF IL6 IL10 IFNA1 CXCL8 CCL5
459 aplastic anemia 10.1 TNF IL6 IL10 IFNA1 HLA-A CXCL8
460 japanese encephalitis 10.1 TNF IFNB1 IFNA1 CXCL10 CLEC4M CD209
461 uveitis 10.1 TNF IL6 IL10 HLA-A CXCL8 CXCL10
462 encephalopathy, progressive, early-onset, with episodic rhabdomyolysis 10.1
463 post-traumatic stress disorder 10.1
464 acute kidney failure 10.1
465 acute stress disorder 10.1
466 cough headache 10.1
467 acute promyelocytic leukemia 10.1 TNF IL6 IL10 IFNA1 CXCL8 CCL2
468 lichen planus 10.0 TNF MX1 IL6 IL10 CXCL8 CCL5
469 colorectal cancer 10.0
470 liver disease 10.0
471 macrophage activation syndrome 10.0
472 integumentary system disease 10.0 TNF IL6 IL10 IFNA1 CXCL8 CXCL10
473 neuritis 10.0 TNF IL6 IL10 CXCL8 CXCL10 CCL5
474 osteomyelitis 10.0 TNF IL6 IL10 CXCL8 CXCL10 CCL5
475 bronchial disease 10.0 TNF IL6 IL10 CXCL8 CXCL10 CCL5
476 interstitial lung disease 10.0 TNF IL6 IL10 CXCL8 CXCL10 CCL5
477 pulmonary fibrosis, idiopathic 10.0 TNF IL6 IL10 CXCL8 CXCL10 CCL5
478 allergic rhinitis 10.0
479 kala-azar 1 10.0
480 pachyonychia congenita 3 10.0
481 noonan syndrome 1 10.0 TNF SH2D3A MX1 IRF3 IFNB1 IFNA1
482 thrombosis 10.0
483 polyneuropathy 10.0
484 pneumothorax 10.0
485 hemolytic anemia 10.0
486 pulmonary embolism 10.0
487 avascular necrosis 10.0
488 lung cancer 10.0
489 variola major 10.0
490 rickets 10.0
491 cholera 10.0
492 urticaria 10.0
493 poliomyelitis 10.0
494 smallpox 10.0
495 crimean-congo hemorrhagic fever 10.0 TNF MX1 IL6 IFNB1 IFNA1 DDX58
496 herpangina 10.0 TNF IRF3 IL6 IL10 IFNB1 IFNA1
497 pyelonephritis 10.0 TNF IL6 IL10 HLA-A CXCL8 CXCL10
498 diabetes mellitus, type i 10.0 TNF IL6 IL10 IFNA1 HLA-A CXCL8
499 heart disease 9.9 TNF IL6 IL10 IFNB1 CXCL8 CCL2
500 hair whorl 9.9
501 polykaryocytosis inducer 9.9
502 greig cephalopolysyndactyly syndrome 9.9
503 leukemia 9.9
504 anthrax disease 9.9
505 neuroblastoma 9.9
506 subacute delirium 9.9
507 chronic pain 9.9
508 skin disease 9.9 TNF MX1 IL6 IL10 DDX58 CXCL8
509 behcet syndrome 9.9 TNF IL6 IL10 IFNB1 IFNA1 HLA-A
510 toxoplasmosis 9.9 TNF IL6 IL10
511 optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy 9.9
512 stroke, ischemic 9.9
513 cryptogenic organizing pneumonia 9.9
514 bone resorption disease 9.9
515 thrombocytosis 9.9
516 transient cerebral ischemia 9.9
517 neuropathy 9.9
518 lupus erythematosus 9.9
519 47,xyy 9.9
520 hepatocellular carcinoma 9.9
521 cardiac conduction defect 9.9
522 fibrosis of extraocular muscles, congenital, 1 9.9
523 huntington disease 9.9
524 leukemia, chronic lymphocytic 9.9
525 migraine with or without aura 1 9.9
526 body mass index quantitative trait locus 11 9.9
527 lung cancer susceptibility 3 9.9
528 neurogenic bladder 9.9
529 miller fisher syndrome 9.9
530 cholestasis 9.9
531 generalized anxiety disorder 9.9
532 epilepsy 9.9
533 gaucher's disease 9.9
534 glioblastoma multiforme 9.9
535 mood disorder 9.9
536 acute myocarditis 9.9
537 ebola hemorrhagic fever 9.9
538 glioma 9.9
539 seizure disorder 9.9
540 glial tumor 9.9
541 mumps 9.8 TNF MX1 IL6 IL10 IFNB1 IFNA1
542 autoimmune disease of central nervous system 9.8 TNF IL6 IL10 IFNB1 IFNA1 CXCL8
543 blood platelet disease 9.8 TNF IL6 IFNA1
544 alzheimer disease 9.8
545 breast cancer 9.8
546 renal cell carcinoma, nonpapillary 9.8
547 prostate cancer 9.8
548 schistosoma mansoni infection, susceptibility/ 9.8
549 cryptorchidism, unilateral or bilateral 9.8
550 cystic fibrosis 9.8
551 gaucher disease, type i 9.8
552 pancreatic cancer 9.8
553 muscular dystrophy, duchenne type 9.8
554 aging 9.8
555 paragangliomas 3 9.8
556 gastrointestinal stromal tumor 9.8
557 leukemia, chronic myeloid 9.8
558 bone mineral density quantitative trait locus 8 9.8
559 major affective disorder 8 9.8
560 major affective disorder 9 9.8
561 microvascular complications of diabetes 5 9.8
562 hypotrichosis and recurrent skin vesicles 9.8
563 bone mineral density quantitative trait locus 15 9.8
564 hypertelorism, preauricular sinus, punctal pits, and deafness 9.8
565 leukemia, acute lymphoblastic 3 9.8
566 mulchandani-bhoj-conlin syndrome 9.8
567 colorectal adenocarcinoma 9.8
568 lymphoma 9.8
569 brain glioma 9.8
570 pneumonic plague 9.8
571 pre-eclampsia 9.8
572 hypospadias 9.8
573 hemopericardium 9.8
574 pericardial effusion 9.8
575 visual epilepsy 9.8
576 newborn respiratory distress syndrome 9.8
577 coccidioidomycosis 9.8
578 alcohol use disorder 9.8
579 thrombocytopenia due to platelet alloimmunization 9.8
580 keratosis 9.8
581 status epilepticus 9.8
582 hypogonadism 9.8
583 kidney cancer 9.8
584 bipolar disorder 9.8
585 skin carcinoma 9.8
586 breast adenocarcinoma 9.8
587 spindle cell carcinoma 9.8
588 hyperglycemia 9.8
589 hypokalemia 9.8
590 movement disease 9.8
591 pancreatitis 9.8
592 acute necrotizing encephalitis 9.8
593 infertility 9.8
594 dystonia 9.8
595 t-cell lymphoblastic leukemia/lymphoma 9.8
596 subacute thyroiditis 9.8
597 actinic keratosis 9.8
598 diabetic macular edema 9.8
599 fatty liver disease 9.8
600 muscular dystrophy 9.8
601 hypoglycemia 9.8
602 candida glabrata 9.8
603 koro 9.8
604 leukemia, t-cell, chronic 9.8
605 parainfluenza virus type 3 9.8
606 polyploidy 9.8
607 dengue hemorrhagic fever 9.8 TNF MX1 IL6 IL10 IFNB1 IFNA1
608 neurofibromatosis, type ii 9.8
609 cardiac arrhythmia 9.8
610 epidermoid cysts 9.8
611 pneumothorax, primary spontaneous 9.8
612 retinoblastoma 9.8
613 thrombophilia due to thrombin defect 9.8
614 thrombophilia due to activated protein c resistance 9.8
615 tracheoesophageal fistula with or without esophageal atresia 9.8
616 triiodothyronine receptor auxiliary protein 9.8
617 volvulus of midgut 9.8
618 acrocallosal syndrome 9.8
619 hypouricemia, renal, 1 9.8
620 enterocolitis 9.8
621 ocular motor apraxia 9.8
622 graves disease 1 9.8
623 arts syndrome 9.8
624 reticuloendotheliosis, x-linked 9.8
625 ventricular fibrillation, paroxysmal familial, 1 9.8
626 coronary heart disease 1 9.8
627 anxiety 9.8
628 legionnaire disease 9.8
629 severe cutaneous adverse reaction 9.8
630 hepatitis c virus 9.8
631 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 9.8
632 heat-shock rna 1 9.8
633 alpha-1-antitrypsin deficiency 9.8
634 influenza, severe 9.8
635 leptin deficiency or dysfunction 9.8
636 analbuminemia 9.8
637 macular dystrophy with central cone involvement 9.8
638 spastic paraplegia, intellectual disability, nystagmus, and obesity 9.8
639 bone disease 9.8
640 aortic dissection 9.8
641 sensorineural hearing loss 9.8
642 oligohydramnios 9.8
643 acute kidney tubular necrosis 9.8
644 guillain-barre syndrome 9.8
645 dementia 9.8
646 critical illness polyneuropathy 9.8
647 hypothyroidism 9.8
648 disease of mental health 9.8
649 melanoma 9.8
650 larynx cancer 9.8
651 lipid metabolism disorder 9.8
652 ischemia 9.8
653 monkeypox 9.8
654 histiocytosis 9.8
655 signet ring cell adenocarcinoma 9.8
656 pustulosis of palm and sole 9.8
657 familial retinoblastoma 9.8
658 severe combined immunodeficiency 9.8
659 cerebrovascular disease 9.8
660 end stage renal disease 9.8
661 diabetic neuropathy 9.8
662 48,xyyy 9.8
663 antisynthetase syndrome 9.8
664 carcinoma showing thymus-like differentiation 9.8
665 stevens-johnson syndrome/toxic epidermal necrolysis 9.8
666 sudden sensorineural hearing loss 9.8
667 autonomic dysfunction 9.8
668 encephalopathy 9.8
669 headache 9.8
670 posttransplant acute limbic encephalitis 9.8
671 rapidly involuting congenital hemangioma 9.8
672 erythema multiforme major 9.8
673 pik3ca-related overgrowth syndrome 9.8
674 x-linked intellectual disability-macrocephaly-macroorchidism syndrome 9.8
675 cardiogenic shock 9.8
676 relapsing-remitting multiple sclerosis 9.7 TNF MX1 IL6 IL10 IFNB1 IFNA1
677 primary bacterial infectious disease 9.7 TNF IL6 IL10 IFNB1 IFNA1 CXCL8
678 rheumatoid arthritis 9.7 TNF IL6 IL10 IFNB1 CXCL8 CXCL10
679 alcohol dependence 9.6
680 atrial standstill 1 9.6
681 bladder cancer 9.6
682 blepharophimosis, ptosis, and epicanthus inversus 9.6
683 coronary artery dissection, spontaneous 9.6
684 creutzfeldt-jakob disease 9.6
685 erythroleukemia, familial 9.6
686 hypertriglyceridemia, familial 9.6
687 pheochromocytoma 9.6
688 dowling-degos disease 1 9.6
689 schizophrenia 9.6
690 scleroderma, familial progressive 9.6
691 suppressor of tumorigenicity 3 9.6
692 vasculitis, lymphocytic, nodular 9.6
693 bloom syndrome 9.6
694 schopf-schulz-passarge syndrome 9.6
695 lymphoma, hodgkin, classic 9.6
696 hypogonadism, male 9.6
697 krabbe disease 9.6
698 kuru 9.6
699 niemann-pick disease, type c1 9.6
700 short stature-obesity syndrome 9.6
701 thymoma, familial 9.6
702 fragile x syndrome 9.6
703 hemophilia a 9.6
704 ataxia and polyneuropathy, adult-onset 9.6
705 yemenite deaf-blind hypopigmentation syndrome 9.6
706 body mass index quantitative trait locus 9 9.6
707 macular degeneration, age-related, 1 9.6
708 body mass index quantitative trait locus 8 9.6
709 cervical cancer 9.6
710 abdominal obesity-metabolic syndrome 1 9.6
711 ciliary dyskinesia, primary, 2 9.6
712 creatinine clearance quantitative trait locus 9.6
713 epilepsy, partial, with pericentral spikes 9.6
714 body mass index quantitative trait locus 4 9.6
715 body mass index quantitative trait locus 10 9.6
716 endometrial cancer 9.6
717 body mass index quantitative trait locus 7 9.6
718 avascular necrosis of femoral head, primary, 1 9.6
719 diabetes mellitus, ketosis-prone 9.6
720 body mass index quantitative trait locus 12 9.6
721 body mass index quantitative trait locus 14 9.6
722 microvascular complications of diabetes 3 9.6
723 premature ovarian failure 7 9.6
724 gastric cancer 9.6
725 cyanosis, transient neonatal 9.6
726 beta-thalassemia 9.6
727 hemorrhage, intracerebral 9.6
728 pulmonary hypertension, primary, 3 9.6
729 body mass index quantitative trait locus 18 9.6
730 alacrima, achalasia, and mental retardation syndrome 9.6
731 neurodegeneration with brain iron accumulation 6 9.6
732 melanoma, cutaneous malignant 10 9.6
733 sting-associated vasculopathy, infantile-onset 9.6
734 neu-laxova syndrome 2 9.6
735 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 9.6
736 hydrops, lactic acidosis, and sideroblastic anemia 9.6
737 neurodevelopmental disorder with microcephaly, ataxia, and seizures 9.6
738 neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures 9.6
739 body mass index quantitative trait locus 19 9.6
740 neuropathy, congenital hypomyelinating, 2 9.6
741 body mass index quantitative trait locus 20 9.6
742 aspiration pneumonia 9.6
743 brugada syndrome 9.6
744 intestinal schistosomiasis 9.6
745 autosomal recessive disease 9.6
746 diffuse large b-cell lymphoma 9.6
747 short qt syndrome 9.6
748 tongue squamous cell carcinoma 9.6
749 oral squamous cell carcinoma 9.6
750 adrenal gland pheochromocytoma 9.6
751 uterine corpus endometrial carcinoma 9.6
752 endocervical adenocarcinoma 9.6
753 immunoglobulin alpha deficiency 9.6
754 cutaneous t cell lymphoma 9.6
755 estrogen-receptor positive breast cancer 9.6
756 pain agnosia 9.6
757 crohn's colitis 9.6
758 atrial fibrillation 9.6
759 catecholaminergic polymorphic ventricular tachycardia 9.6
760 physical disorder 9.6
761 cerebral artery occlusion 9.6
762 dermatomyositis 9.6
763 thalassemia 9.6
764 parotitis 9.6
765 charcot-marie-tooth disease 9.6
766 glucose intolerance 9.6
767 malignant essential hypertension 9.6
768 murray valley encephalitis 9.6
769 st. louis encephalitis 9.6
770 tooth disease 9.6
771 amnestic disorder 9.6
772 pseudomembranous conjunctivitis 9.6
773 diphtheria 9.6
774 cardiac tamponade 9.6
775 portal vein thrombosis 9.6
776 nephrotic syndrome 9.6
777 coronary thrombosis 9.6
778 hypertrophic cardiomyopathy 9.6
779 male infertility 9.6
780 acute leukemia 9.6
781 keratoconjunctivitis sicca 9.6
782 relapsing fever 9.6
783 tick-borne relapsing fever 9.6
784 severe pre-eclampsia 9.6
785 rift valley fever 9.6
786 glanders 9.6
787 osteopetrosis 9.6
788 eclampsia 9.6
789 biliary atresia 9.6
790 blue toe syndrome 9.6
791 azoospermia 9.6
792 capillary leak syndrome 9.6
793 niemann-pick disease 9.6
794 respiratory system disease 9.6
795 renovascular hypertension 9.6
796 squamous cell carcinoma 9.6
797 cheilitis 9.6
798 bone cancer 9.6
799 impotence 9.6
800 hyperuricemia 9.6
801 rectum cancer 9.6
802 rectum adenocarcinoma 9.6
803 myeloproliferative neoplasm 9.6
804 focal epilepsy 9.6
805 colon adenocarcinoma 9.6
806 west nile encephalitis 9.6
807 west nile fever 9.6
808 acromegaly 9.6
809 thrombophilia 9.6
810 hematologic cancer 9.6
811 long qt syndrome 9.6
812 congenital nonspherocytic hemolytic anemia 9.6
813 cervix carcinoma 9.6
814 substance abuse 9.6
815 astrocytoma 9.6
816 thoracic outlet syndrome 9.6
817 thymoma 9.6
818 embryonal carcinoma 9.6
819 mammary paget's disease 9.6
820 mastocytosis 9.6
821 cervical squamous cell carcinoma 9.6
822 pleural empyema 9.6
823 insulinoma 9.6
824 lung squamous cell carcinoma 9.6
825 pancreatic adenocarcinoma 9.6
826 carcinosarcoma 9.6
827 polyradiculoneuropathy 9.6
828 lung large cell carcinoma 9.6
829 placenta accreta 9.6
830 adjustment disorder 9.6
831 liver cirrhosis 9.6
832 demyelinating polyneuropathy 9.6
833 scrapie 9.6
834 panic disorder 9.6
835 congestive heart failure 9.6
836 uterine carcinosarcoma 9.6
837 acute disseminated encephalomyelitis 9.6
838 prion disease 9.6
839 b-cell lymphoma 9.6
840 active peptic ulcer disease 9.6
841 peptic ulcer perforation 9.6
842 childhood leukemia 9.6
843 delusional disorder 9.6
844 cocaine abuse 9.6
845 cataract 9.6
846 eating disorder 9.6
847 skin melanoma 9.6
848 amyloidosis 9.6
849 gas gangrene 9.6
850 pemphigus 9.6
851 carotid artery dissection 9.6
852 placental abruption 9.6
853 hypersensitivity vasculitis 9.6
854 hemophilia 9.6
855 sickle cell disease 9.6
856 acquired hemophilia 9.6
857 acquired hemophilia a 9.6
858 anca-associated vasculitis 9.6
859 bk-virus nephropathy 9.6
860 broken heart syndrome 9.6
861 catastrophic antiphospholipid syndrome 9.6
862 coronary artery aneurysm 9.6
863 granulocytopenia 9.6
864 mast cell activation syndrome 9.6
865 oral cancer 9.6
866 perniosis 9.6
867 renal cell carcinoma 4 9.6
868 ring chromosome 13 9.6
869 ring chromosome 3 9.6
870 ring chromosome 5 9.6
871 splenomegaly 9.6
872 virus associated hemophagocytic syndrome 9.6
873 aneurysm 9.6
874 dysautonomia 9.6
875 dysphagia 9.6
876 meningitis and encephalitis 9.6
877 syncope 9.6
878 tremor 9.6
879 systemic autoimmune disease 9.6
880 perioral myoclonia with absences 9.6
881 endotheliitis 9.6
882 hemophagocytic syndrome associated with an infection 9.6
883 inflammatory myopathy with abundant macrophages 9.6
884 chronic intestinal failure 9.6
885 benign idiopathic neonatal seizures 9.6
886 serotonin syndrome 9.6
887 acute liver failure 9.6
888 infectious encephalitis 9.6
889 ovarian cancer 9.5 TNF IL6 IL10 IFNA1 HLA-A CXCL8

Graphical network of the top 20 diseases related to Severe Acute Respiratory Syndrome:



Diseases related to Severe Acute Respiratory Syndrome

Symptoms & Phenotypes for Severe Acute Respiratory Syndrome

Human phenotypes related to Severe Acute Respiratory Syndrome:

58 (showing 16, show less)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 fever 58 Frequent (79-30%)
2 abnormality of the cardiovascular system 58 Occasional (29-5%)
3 dyspnea 58 Frequent (79-30%)
4 immunodeficiency 58 Frequent (79-30%)
5 myalgia 58 Frequent (79-30%)
6 cough 58 Very frequent (99-80%)
7 neoplasm 58 Occasional (29-5%)
8 diabetes mellitus 58 Occasional (29-5%)
9 headache 58 Frequent (79-30%)
10 respiratory failure requiring assisted ventilation 58 Occasional (29-5%)
11 respiratory distress 58 Frequent (79-30%)
12 hypoxemia 58 Occasional (29-5%)
13 acute kidney injury 58 Very rare (<4-1%)
14 acute infectious pneumonia 58 Occasional (29-5%)
15 chronic lung disease 58 Occasional (29-5%)
16 pharyngitis 58 Occasional (29-5%)

Symptoms:

12 (showing 5, show less)
  • fever
  • headache
  • dry cough
  • body aches
  • hypoxia

UMLS symptoms related to Severe Acute Respiratory Syndrome:


fever, pruritus, snoring, coughing

MGI Mouse Phenotypes related to Severe Acute Respiratory Syndrome:

45 (showing 1, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 immune system MP:0005387 9.44 ACE2 CCL2 CCL5 CLEC4M CXCL10 DDX58

Drugs & Therapeutics for Severe Acute Respiratory Syndrome

Drugs for Severe Acute Respiratory Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 579, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ziprasidone Approved Phase 4 146939-27-7 60854
2
Liraglutide Approved Phase 4 204656-20-2 44147092
3
Glucagon Approved Phase 4 16941-32-5
4
Prednisolone phosphate Approved, Vet_approved Phase 4 302-25-0
5
Methylprednisolone Approved, Vet_approved Phase 4 83-43-2 6741
6
Methylprednisolone hemisuccinate Approved Phase 4 2921-57-5
7
Prednisolone Approved, Vet_approved Phase 4 50-24-8 5755
8 Prednisolone acetate Approved, Vet_approved Phase 4 52-21-1
9
Azithromycin Approved Phase 4 83905-01-5 447043 55185
10
Losartan Approved Phase 4 114798-26-4 3961
11
Ibuprofen Approved Phase 4 15687-27-1 3672
12
Protein C Approved Phase 4
13
Captopril Approved Phase 4 62571-86-2 44093
14
Clarithromycin Approved Phase 4 81103-11-9 84029
15
Oseltamivir Approved Phase 4 204255-11-8, 196618-13-0 65028
16
Heparin Approved, Investigational Phase 4 9005-49-6 46507594 772
17
Budesonide Approved Phase 4 51333-22-3 63006 5281004
18
Clavulanate Approved, Vet_approved Phase 4 58001-44-8 5280980
19
Amoxicillin Approved, Vet_approved Phase 4 26787-78-0 33613
20
Tinzaparin Approved Phase 4 9041-08-1, 9005-49-6 25244225
21
Dalteparin Approved Phase 4 9005-49-6
22
Eprosartan Approved Phase 4 133040-01-4 5281037
23
Nicardipine Approved, Investigational Phase 4 55985-32-5 4474
24
Perindopril Approved Phase 4 107133-36-8, 82834-16-0 107807
25
Enalapril Approved, Vet_approved Phase 4 75847-73-3 40466924 5362032
26
Trandolapril Approved Phase 4 87679-37-6 5484727
27
Hydrochlorothiazide Approved, Vet_approved Phase 4 58-93-5 3639
28
Lisinopril Approved, Investigational Phase 4 76547-98-3, 83915-83-7 5362119
29
Irbesartan Approved, Investigational Phase 4 138402-11-6 3749
30
Valsartan Approved, Investigational Phase 4 137862-53-4 60846